open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Maternal & Public Health

Abortion Reporting: Rhode Island (2022)

This national report shows that between 2021 (2,175 abortions) and 2022 (1,383 abortions), abortions decreased by 36% overall with drug-induced abortions decreasing by 76%.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025
Maternal & Public Health

Abortion Reporting: New Mexico (2022)

According to the CDC, 11,735 abortions were performed in New Mexico in 2022, an increase of 140% from 2021.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025
Maternal & Public Health

Abortion Reporting: Hawaii (2022)

According to the CDC report, there were 1,970 abortions reported in Hawaii in 2022, a decrease of 11% from 2021 when there were 2,214 reported abortions.

Mia Steupert, M.A. Elyse Gaitan
January 8, 2025
Life & the Law

Strengthening the Pro-Life Safety Net: Federal Transportation Policy

Laid out below are specific ways the U.S. Department of Transportation (DOT) could offer material support to address transportation requirements for pregnant and parenting women in need by leveraging existing programs, including direct aid and funding for transportation programs for that purpose.

Christopher C. Hull,…
December 20, 2024
End of Year Update: Tax Credits for Life-Affirming Organizations
Life & the Law

End of Year Update: Tax Credits for Life-Affirming Organizations

Many states and localities have established special tax credits intended to incentivize contributions to pregnancy help organizations. This paper contains a summary of tax credits offered by various states which may be applicable to life-affirming 501(c)(3) organizations.

Jeanneane Maxon, J.D.
December 19, 2024
Life & the Law

Fact Sheet: Abortions at or after 15 Weeks in the United States

Modern scientific literature shows that unborn babies can feel pain by 15 weeks gestation, and possibly as early as 12 weeks. The majority of abortions occur in the first trimester, but a substantial number are performed at 15 weeks or later on unborn babies who are capable of experiencing pain. Available data suggests that tens of thousands of abortions on unborn babies who feel pain are performed at 15 weeks or later each year.

charlotte-lozier-institute Charlotte Lozier Institute
December 19, 2024
Life & the Law

Fact Sheet: Questions and Answers on Born-Alive Abortion Survivors

This fact sheet unpacks the reality of born-alive abortion survivors in the United States.

charlotte-lozier-institute Charlotte Lozier Institute
December 19, 2024
Fact Sheet: A Summary of the CDC’s 2022 Abortion Surveillance Report
Abortion

Fact Sheet: A Summary of the CDC’s 2022 Abortion Surveillance Report

The CDC released its annual abortion surveillance report on November 28, detailing 2022 abortion data in 48 reporting areas (46 states, NYC, and D.C.). Included in this fact sheet are key data points from that report.

Mia Steupert, M.A. Tessa Cox
December 18, 2024

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image